Anipamil

Anipamil

SCHEMBL31479919

CCCCCCCCCCCCC(C#N)(CCCN(C)CCc1cccc(OC)c1)c1cccc(OC)c1

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.69
EBP Q15125 3/20 0.69
AOC3 Q16853 1/20 0.44
ABCB1 P08183 7/20 0.43
CYP3A4 P08684 5/20 0.43
ABCC1 P33527 4/20 0.43
KCNH2 Q12809 3/20 0.43
TSHR P16473 3/20 0.43
LMNA P02545 3/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
CYP2C19 P33261 2/20 0.43
ABCB11 O95342 2/20 0.43
CACNA1F O60840 2/20 0.43
HTR1A P08908 2/20 0.43
ADRA2A P08913 2/20 0.43
DRD2 P14416 2/20 0.43
ADRA2C P18825 2/20 0.43
HTR2A P28223 2/20 0.43
HTR2C P28335 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anipamil SCHEMBL247837 1.00 SIGMAR1 (0.69) SIGMAR1EBPAOC3ABCB1CYP3A4
Anipamil SCHEMBL9177433 0.99 SIGMAR1 (0.67) SIGMAR1EBPAOC3ABCB1CYP3A4
Anipamil SCHEMBL7199272 0.99 SIGMAR1 (0.67) SIGMAR1EBPAOC3ABCB1CYP3A4
SCHEMBL24224796 0.92 SIGMAR1 (0.60) SIGMAR1EBPAOC3ABCB1CYP3A4
Dagapamil SCHEMBL2110079 0.90 SIGMAR1 (0.60) SIGMAR1EBPAOC3ABCB1CYP3A4
Anipamil SCHEMBL1897642 0.84 SIGMAR1 (0.52) SIGMAR1EBPAOC3ABCB1CYP3A4
SCHEMBL7322417 0.83 CHRM2 (0.46) SIGMAR1EBPABCB1CYP3A4MEN1
Ronipamil SCHEMBL1814126 0.82 SIGMAR1 (1.00) SIGMAR1EBPKCNH2SLC6A4CHRM2
Anipamil SCHEMBL741478 0.81 SCN1A (0.62) SIGMAR1EBPABCB1CYP3A4ABCC1
SCHEMBL9490822 0.80 SIGMAR1 (0.53) SIGMAR1EBPAOC3ABCB1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025050228-A1 PHARMACEUTICAL COMPOSITION COMPRISING A PEPTIDE OR A COMBINATION OF PEPTIDES AGONISTIC TO THE MAS, AT1 AND AT2 RECEPTORS PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE (CL) 2025-03-13 WO claimed
WO-2025050228-A1 PHARMACEUTICAL COMPOSITION COMPRISING A PEPTIDE OR A COMBINATION OF PEPTIDES AGONISTIC TO THE MAS, AT1 AND AT2 RECEPTORS PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE (CL) 2025-03-13 WO disclosed